Amgen Drug Delivers More Weight Loss Than Competitors
A new weight loss drug developed by Amgen may provide better results with fewer injections than current treatments such as Ozempic and Wegovy, according to the results of a recent trial. Trial participants who were obese or overweight lost an average of 20 percent of their body weight in 12 months without their weight loss plateauing,
What to Know About Biden’s Plan for Weight-Loss Drugs, Medicaid and Medicare
The Biden administration proposed a rule for Medicare and Medicaid to cover the costs of weight-loss drugs for millions of Americans with obesity.
Wegovy costs $1,349 in the US vs. $92 in the UK. Why are weight loss drugs so pricey?
About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce risks with obesity.
New Drug Causes 20 Percent Weight Loss in Early Amgen Results
The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 percent of their weight in a year. The drug, MariTide, is given by injection once a month, compared with once a week for other obesity drugs like Wegovy and Zepbound that are already on the market.
Medicare proposes covering weight-loss drugs, teeing up clash with RFK Jr.
The proposal would expand coverage of anti-obesity drugs to 7.5 million people covered by Medicare and Medicaid, the Biden administration said.
Biden wants to cover weight loss meds. RFK Jr. would rather we just eat better.
The Biden administration proposed expanding coverage of weight loss medication to Medicaid and Medicare recipients. RFK Jr. may not be such a fan.
Weight-loss-drug makers’ stocks get a boost from new Biden coverage proposal, but will it hold up?
The stocks of companies that make the new class of drugs to treat obesity and manage diabetes were higher across the board early Tuesday, after the Biden administration proposed a rule that would allow Medicare or Medicaid to cover the expensive medications.
Cheap Ozempic? How millions of Americans with obesity may get access to costly weight-loss drugs
Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 billion proposal from the Biden administration is blessed by President-elect Donald Trump.
Thanksgiving may feel different for Americans on weight loss drugs. Here's why.
This may be the first Thanksgiving for millions of Americans who are on GLP-1 agonists like Ozempic, Zepbound or Wegovy.
Biden proposes Medicare, Medicaid cover pricey weight-loss drugs for obese Americans
Millions of Americans could soon have access to weight-loss medications that some have called "miracle drugs."
Biden proposes Medicare and Medicaid cover costly weight-loss drugs for millions of obese Americans
Millions of Americans would be eligible to have costly weight-loss drugs like Wegovy or Ozempic covered by Medicare or Medicaid under the rule.
Shaq tosses hilarious quip at Charles Barkley for his weight loss: 'Ozempic FBI!'
"Inside the NBA" featured some more cracks between colleagues on Tuesday night, as Shaquille O'Neal called for the "Ozempic ...
Aging, weight loss and a gift guide: The week in Well+Being
You are reading our weekly Well+Being newsletter. Sign up here to get it delivered to your inbox every Thursday. Happy ...
‘Euphoria’ star Barbie Ferreira shocks fans with dramatic weight loss transformation
Barbie Ferreira has sent fans into a frenzy over her dramatic weight loss transformation. Viral photos of the “Euphoria” star ...
Important NHS weight loss rule that contradicts trendy intermittent fasting advice
The NHS has shared its 12 Tips to Help You Lose Weight - and the number one rule completely contradicts the trendy dieting ...
Shaq’s Funny Line About Ozempic Had ‘Inside the NBA’ Crew Cracking Up
You already got the fat cut,” Barkley chimed in, slipping in a funny quip. “Ozempic still looking for your a--,” Shaq said to Barkley. “Ozempic, I’m snitching, he’s right here. Ozempic FBI, he’s right ...
What's Next for Amgen Obesity Drug After Investors Disappointed by Results
Shares in Amgen fell on Tuesday after they announced the results of a trial for their weight loss drug MariTide.